Neurocrine Biosciences Stock Price - NBIX

0.00 (0.0%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Neurocrine Biosciences Inc NBIX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 123.40 0.00 0.00 0.00 123.40 07:00:00
Bid Price Ask Price Spread Spread % News
120.63 126.00 5.37 4.26% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 123.40 USD

Neurocrine Biosciences Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 11.46B 92.87M 90.77M $ 788.09M $ 159.59M 0.34 64.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Neurocrine Biosciences News

Date Time Source News Article
5/29/202016:14PR Newswire (US)FDA Approves the First Oral Medication for the Management of..
5/26/202016:01PR Newswire (US)Neurocrine Biosciences to Present at the Jefferies Virtual..
5/21/202019:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/21/202019:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/21/202018:57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/21/202018:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
5/21/202018:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NBIX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week127.73128.29112.27121.30886,197-4.33-3.39%
1 Month100.00128.2999.38116.79959,23323.4023.4%
3 Months91.06128.2972.1499.40855,06832.3435.52%
6 Months117.78128.2972.14102.52836,5885.624.77%
1 Year85.51128.2972.14100.02765,72137.8944.31%
3 Years44.90128.2941.7686.41837,76478.50174.83%
5 Years41.25128.2931.2568.63896,25782.15199.15%

Neurocrine Biosciences Description

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200602 12:24:14